?Estradiol-3-Benzoate-17-Butyrate | Hormone Intermediate | Pharmaceutical Grade API?
■■■■■■■■■■■■■■■■■■■■

?Product Overview?
Estradiol-3-Benzoate-17-Butyrate is a high-purity steroid derivative used as a key intermediate in synthesizing advanced hormone therapies and oncology APIs?14. Its dual ester structure enhances bioavailability and stability, making it ideal for long-acting contraceptive formulations, estrogen replacement drugs, and targeted cancer treatments?25.

?Key Advantages?
? ?>99.5% HPLC-Verified Purity?: Rigorous quality control ensures compliance with USP/EP pharmacopeia standards?23.
? ?Extended Half-Life?: Optimized pharmacokinetics for sustained-release formulations (T? >72 hours)?34.
? ?GMP-Certified Production?: Full traceability from raw materials to final packaging?24.

?Applications?
? ?Hormone Replacement Therapies?: Menopause management and osteoporosis prevention?14.
? ?Oncology Drug Development?: Estrogen receptor modulators for breast and prostate cancer?35.
? ?Veterinary Pharmaceuticals?: Fertility regulation in livestock and companion animals?34.

?Quality Certifications?
■ ?USP <467> Compliance?: Residual solvents (methanol, ethyl acetate) below 50 ppm?24.
■ ?Stability-Tested?: 36-month shelf life under 15-25°C storage with light protection?23.

?Market Trends?
The global hormone therapy market is projected to reach ?$35.2 billion by 2030?, driven by aging populations and rising oncology R&D investments?45. Estradiol derivatives dominate ?22% of the contraceptive API segment?, with CAGR of 8.3% in oncology applications?34.

■■■■■■■■■■■■■■■■■■■■
?High-Value Keywords?:

• Hormone Therapy Intermediate

• Pharmaceutical Grade API Synthesis

• USP-Compliant Steroid Derivative

• Long-Acting Contraceptive Precursor

• Oncology Drug Development

?Google Search Optimized Terms?:

• GMP-Certified Hormone Intermediate

• High-Purity Estradiol Derivative

• Stability-Tested Oncology API

• USP/EP Pharmaceutical Compliance

• Veterinary Fertility Regulation